4//SEC Filing
Okazaki Jason A 4
Accession 0001209191-23-021868
CIK 0001426800other
Filed
Mar 30, 8:00 PM ET
Accepted
Mar 31, 4:30 PM ET
Size
8.5 KB
Accession
0001209191-23-021868
Insider Transaction Report
Form 4
Okazaki Jason A
DirectorCEO and President
Transactions
- Sale
Common Stock
2023-03-30$0.82/sh−4,247$3,496→ 98,174 total - Award
Stock Option (right to buy)
2023-03-29+470,000→ 470,000 totalExercise: $0.89Exp: 2033-03-29→ Common Stock (470,000 underlying)
Footnotes (3)
- [F1]The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units ("RSUs"). The sale is mandated by an administrative rule adopted by the Compensation Committee of the Issuer's Board of Directors that requires the satisfaction of tax withholding obligations to be funded by a "sell-to-cover" transaction and does not represent a discretionary transaction by the reporting person.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.7795 to $0.89, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within.
- [F3]Grant of stock options. The stock options vest over four years, assuming continuous service on each vesting date, as follows: 25% vest on the first anniversary of the date of grant, March 29, 2024; and the remaining 75% vest in 36 approximately equal monthly installments, with the options becoming fully vested on March 29, 2027.
Documents
Issuer
ASSEMBLY BIOSCIENCES, INC.
CIK 0001426800
Entity typeother
Related Parties
1- filerCIK 0001807214
Filing Metadata
- Form type
- 4
- Filed
- Mar 30, 8:00 PM ET
- Accepted
- Mar 31, 4:30 PM ET
- Size
- 8.5 KB